Shehnaaz Suliman
Director/Board Member presso ULTRAGENYX PHARMACEUTICAL INC.
Patrimonio netto: 866 593 $ in data 31/03/2024
Posizioni attive di Shehnaaz Suliman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Director/Board Member | 30/01/2019 | - |
| Independent Dir/Board Member | 30/01/2019 | - | |
| 10X GENOMICS, INC. | Director/Board Member | 01/08/2019 | - |
| Independent Dir/Board Member | 01/08/2019 | - | |
Executive Women in Bio
 Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Chairman | - | - |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Director/Board Member | 11/01/2022 | - |
| Chief Executive Officer | 11/01/2022 | - |
Storia della carriera di Shehnaaz Suliman
Precedenti posizioni note di Shehnaaz Suliman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ALECTOR, INC. | Chief Executive Officer | 11/12/2019 | 15/12/2021 |
| Chief Operating Officer | 11/12/2019 | 01/01/2022 | |
| President | 11/12/2019 | 15/12/2021 | |
Parvus Therapeutics, Inc.
 Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Director/Board Member | 01/10/2017 | 01/07/2019 |
| THERAVANCE BIOPHARMA, INC. | Corporate Officer/Principal | 01/07/2017 | 31/03/2019 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/06/2015 | 01/07/2017 |
Formazione di Shehnaaz Suliman
| University of Oxford | Graduate Degree |
| University of Cape Town | Doctorate Degree |
| Saïd Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 3 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 2 |
Settori
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| ALECTOR, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Parvus Therapeutics, Inc.
Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada. | Health Technology |
Executive Women in Bio
Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development. | Commercial Services |
- Borsa valori
- Insiders
- Shehnaaz Suliman
- Esperienza
